Where do we stand with CAR-T therapy? Could checkpoint inhibitors apply in CLL? CLL expert Dr. William Wierda, from the 2015 American Society of Hematology (ASH) meeting, shares his insights into this exploding field of research. Dr. Wierda explains developing immunotherapy options, including CAR T-cell therapies, which he feels hold the most hope as a curative strategy for CLL.CAR-T Cell Therapy is the next step to cure patients with CLL.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Advertisement